financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP to sell its US onshore wind business
BP to sell its US onshore wind business
Sep 16, 2024
* BP to integrate onshore renewable power into Lightsource bp * Says sale process to start shortly (Adds detail from statement and background throughout) Sept 16 (Reuters) - BP plans to sell its U.S. onshore wind energy business, it announced on Monday, saying the assets were not aligned with its growth plans. BP said it will launch the sale process...
Kyverna Therapeutics Names Warner Biddle CEO
Kyverna Therapeutics Names Warner Biddle CEO
Sep 16, 2024
09:01 AM EDT, 09/16/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said Monday that it has appointed Warner Biddle to succeed Peter Maag as chief executive officer, effective immediately. Biddle previously served as senior vice president and global head of commercial for Kite Pharma, a Gilead (GILD) company. Price: 7.44, Change: +0.24, Percent Change: +3.33 ...
Carl Icahn welcomes dismissal of Icahn Enterprises lawsuit, not selling shares
Carl Icahn welcomes dismissal of Icahn Enterprises lawsuit, not selling shares
Sep 16, 2024
(Reuters) - Carl Icahn said on Monday he was pleased a federal judge dismissed a lawsuit accusing the billionaire of defrauding shareholders of his investment company Icahn Enterprises ( IEP ) so he could obtain large amounts of personal loans. The lawsuit followed a May 2023 report by the short-selling firm Hindenburg Research that questioned whether Icahn's company inflated its...
Jazz Pharmaceuticals Says Gastric Cancer Therapy Shows Promise in Mid-Stage Study
Jazz Pharmaceuticals Says Gastric Cancer Therapy Shows Promise in Mid-Stage Study
Sep 16, 2024
08:54 AM EDT, 09/16/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Monday that updated data from the mid-stage study of its experimental therapy, zanidatamab, combined with chemotherapy for HER2-positive advanced or metastatic gastroesophageal adenocarcinoma were positive. Data showed that among 41 patients treated with zanidatamab in combination with chemotherapy, the median progression-free survival was 15.2 months, and the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved